Otonomy to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Corporate Update

Back to Jobs

SAN DIEGO , Feb. 20, 2020 (GLOBE NEWSWIRE) — Otonomy , Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it will report financial results for the fourth quarter and full year 2019 as well as provide a corporate

Apply Now